Greenway Medical Technologies (NYSE: GWAY) reported earnings on May 6. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q3), Greenway Medical Technologies missed slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew slightly. Non-GAAP earnings per share dropped significantly. GAAP earnings per share shrank to a loss.

Margins dropped across the board.

Revenue details
 Greenway Medical Technologies reported revenue of $33.8 million. The seven analysts polled by S&P Capital IQ anticipated revenue of $34.3 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.01. The four earnings estimates compiled by S&P Capital IQ predicted -$0.02 per share. Non-GAAP EPS of $0.01 for Q3 were 88% lower than the prior-year quarter's $0.08 per share. GAAP EPS were -$0.02 for Q3 against $0.06 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 49.8%, 510 basis points worse than the prior-year quarter. Operating margin was -8.3%, much worse than the prior-year quarter. Net margin was -1.8%, 600 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $34.5 million. On the bottom line, the average EPS estimate is $0.05.

Next year's average estimate for revenue is $135.0 million. The average EPS estimate is $0.09.

Investor sentiment
 The stock has a one-star rating (out of five) at Motley Fool CAPS, with 16 members out of 29 rating the stock outperform, and 13 members rating it underperform. Among seven CAPS All-Star picks (recommendations by the highest-ranked CAPS members), three give Greenway Medical Technologies a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Greenway Medical Technologies is outperform, with an average price target of $17.00.

Is Greenway Medical Technologies the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.